Power Shares DWA動量投資組合 PDP 深 滬
等待開盤 09-29 09:30:00 美东时间
116.5504
+1.329
+1.15%
華盛通- 最 高116.5504
- 今 開115.69
- 成交量 1.94万股
- 最 低 115.61
- 昨 收 115.2212
- 總市值 13.68亿
- 52周最高 118.00
- 市盈率 靜 --
- 換手率 0.17%
- 52周最低 86.2537
- 委 比 12.90%
- 總股本 1174.00万
- 歷史最高 118.00
- 量 比 0.68
- 振 幅 0.82%
- 歷史最低 24.6649
- 每 手 1
- 風險率 5.85%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多天风证券：维持绿叶制药“买入”评级 在研管线具备差异化优势
天风证券发布研报称，考虑到市场竞争激烈和集采影响，将绿叶制药（02186）2025至2026年营业收入从85.29亿元、102.79亿元下调至66.38亿元...
今天 14:12
- Chord Energy Reveals Strategic Acquisition Of Williston Basin Assets; Acquisition Valued At $550M; Deal Expected To Be Accretive To All Key Metrics Including Cash Flow, Free Cash Flow And NAV In Both Near And Long-Term
HOUSTON, Sept. 15, 2025 /PRNewswire/ -- Chord Energy Corporation (NASDAQ:CHRD) ("Chord", "Chord Energy" or the "Company") today announced that a wholly owned subsidiary of Chord has entered into a definitive agreement to
09-16 05:03
Assessing ACADIA Pharmaceuticals: Insights From 12 Financial Analysts
In the last three months, 12 analysts have published ratings on ACADIA Pharmace...
09-10 02:01
Nvidia's Earnings Could Make Or Break Momentum ETFs
Goldman Sachs traders predict a reversal for momentum stocks, putting pressure on ETFs linked to factors ahead of Nvidia's earnings next week.
08-22 02:03
Momentum movers: 10 large-caps beating the benchmarks
Wall Street’s major averages continue to hover near record highs, suggesting the broader market may be entering a period of consolidation. Still, beneath the surface, several individual names are show...
08-19 20:55
视涯科技冲击IPO，专注于硅基OLED微型显示屏，三年亏损近8亿
近期，AI产业链赚钱效应拉满，尤其是算力相关的个股，自4月以来有不少都录得翻倍以上的涨幅，包括工业富联、新易盛、中际旭创、天孚通信、胜宏科技、鹏鼎控股、英维克等...
08-15 16:43
Humana Boosts 2025 Profit Guidance, Plans $100 Million In Strategic Investments
Humana beat Q2 EPS and revenue estimates and raised its 2025 outlook, driven by strong PDP growth and higher CenterWell patient volumes.
07-30 21:49
Centene's First Quarterly Loss In 13 Years Sends Shares Crashing
Centene reported a Q2 loss and pulled its 2025 guidance despite rising revenue, citing higher healthcare costs and shifting risk adjustment estimates.
07-25 21:01
What Analysts Are Saying About ACADIA Pharmaceuticals Stock
18 analysts have shared their evaluations of ACADIA Pharmaceuticals (NASDAQ:ACA...
07-25 02:01
